World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
69879
World Ranking
7482
National Ranking
39

Irene M. Lang publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Irene M. Lang sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 631 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Irene M. Lang D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Irene M. Lang sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Irene M. Lang is affiliated with the Medical University of Vienna in Austria. Their research primarily spans the field of Medicine, with a focus on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery, Epidemiology, and Internal Medicine. The subfields demonstrate a multidisciplinary approach toward studying complex cardiovascular and pulmonary conditions.

Their main topics of work include pulmonary hypertension research and treatments, venous thromboembolism diagnosis and management, acute myocardial infarction research, coronary interventions and diagnostics, cardiovascular function and risk factors, cardiac valve diseases and treatments, and cardiac imaging and diagnostics.

Frequently publishing in scientific journals, Irene M. Lang has contributed extensively to:

  • European Heart Journal
  • The Journal of Heart and Lung Transplantation
  • Journal of the American College of Cardiology
  • Atherosclerosis
  • Circulation

Significant recent papers include:

  • 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, 2022, European Heart Journal
  • 2020 ESC Guidelines for the management of adult congenital heart disease, 2020, European Heart Journal
  • Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction, 2022, JAMA
  • ERS statement on chronic thromboembolic pulmonary hypertension, 2020, European Respiratory Journal
  • Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society, 2021, European Heart Journal

Irene M. Lang collaborates frequently with several co-authors, including:

  • Christian Hengstenberg
  • Christian Gerges
  • Anna S. Ondracek
  • Thomas M. Hofbauer
  • Nika Skoro-Sajer

Their work consistently contributes to advancing understanding and treatment approaches in cardiopulmonary medicine, reflected through interdisciplinary research and co-authorship networks. The broad scope of publications and topics illustrates a comprehensive engagement with current challenges in cardiovascular and pulmonary diseases.

Best Publications

  • 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

    Nazzareno Galiè;Marc Humbert;Jean-Luc Vachiery;Simon Gibbs

  • Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)

    Adam Torbicki;Arnaud Perrier;Stavros Konstantinides;Giancarlo Agnelli

  • 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)

    Stavros Konstantinides;Guy Meyer;Cecilia Becattini;Héctor Bueno

  • [2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].

    Nazzareno Galiè;Marc Humbert;Jean-Luc Vachiery;Simon Gibbs

  • 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy

    Vera Regitz-Zagrosek;Jolien W Roos-Hesselink;Johann Bauersachs;Carina Blomstrom-Lundqvist

  • Fibrinolysis for Patients with Intermediate- Risk Pulmonary Embolism

    Guy Meyer;Eric Vicaut;Thierry Danays;Giancarlo Agnelli

  • Predictors of outcome in severe, asymptomatic aortic stenosis.

    Raphael Rosenhek;Thomas Binder;Gerold Porenta;Irene Lang

  • Guidelines for the diagnosis and treatment of pulmonary hypertension

    Marius M. Hoeper;Marc Humbert;Adam Torbicki;Jean-Luc Vachiery

  • 2020 ESC Guidelines for the management of adult congenital heart disease.

    Helmut Baumgartner;Julie De Backer;Sonya V Babu-Narayan;Werner Budts

  • 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism

    Stavros Konstantinides;Stavros Konstantinides;Adam Torbicki;Giancarlo Agnelli;Nicolas Danchin

  • Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Results From an International Prospective Registry

    Joanna Pepke-Zaba;Marion Delcroix;Irene Lang;Eckhard Mayer

  • 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) : The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)

    Stavros V. Konstantinides;Guy Meyer;Cecilia Becattini;Héctor Bueno

  • Chronic Thromboembolic Pulmonary Hypertension

    Nick H. Kim;Marion Delcroix;David P. Jenkins;Richard Channick

  • Selexipag for the treatment of pulmonary arterial hypertension.

    Olivier Sitbon;Richard Channick;Kelly M Chin;Aline Frey

  • Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registry

    Eckhard Mayer;David Jenkins;Jaroslav Lindner;Andrea D’Armini

  • 2020 ESC Guidelines for the management of adult congenital heart disease

    Helmut Baumgartner;Julie De Backer;Sonya V. Babu-Narayan;Werner Budts

  • Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.

    Xavier Jaïs;Andrea M. D'Armini;Pavel Jansa;Adam Torbicki

  • Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry.

    Marion Delcroix;Irene Lang;Joanna Pepke-Zaba;Pavel Jansa

  • Special article2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension

    Nazzareno Galiè;Marc Humbert;Jean-Luc Vachiery;Simon Gibbs

  • 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension - web addenda

    Nazzareno Galiè;Marc Humbert;Jean-Luc Vachiery;Simon Gibbs

Frequent Co-Authors

Gerald Maurer
Gerald Maurer Medical University of Vienna
Walter Klepetko
Walter Klepetko Medical University of Vienna
Marius M. Hoeper
Marius M. Hoeper Hannover Medical School
Nazzareno Galiè
Nazzareno Galiè University of Bologna
Hossein Ardeschir Ghofrani
Hossein Ardeschir Ghofrani University of Giessen
Gérald Simonneau
Gérald Simonneau University of Paris-Saclay
Stavros Konstantinides
Stavros Konstantinides Democritus University of Thrace
Olivier Sitbon
Olivier Sitbon University of Paris-Saclay
Lewis J. Rubin
Lewis J. Rubin University of California, San Diego
Adam Torbicki
Adam Torbicki Center for Postgraduate Medical Education at ECZ-Otwock

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering Medicine in the USA, there are several related online degrees and career pathways worth exploring. The healthcare field is vast, offering flexible options that can align with your interests, background, and career goals.

For those interested in patient care roles, nursing programs without teas present a convenient path to becoming a nurse without traditional admission exam barriers. Similarly, if you have an associate degree in nursing, you may consider adn to np programs online to smoothly transition into advanced practice nursing roles.

Those preferring administrative roles can pursue a health care administration degree. These programs equip you with leadership and management skills for the modern healthcare environment. Alternatively, if you’re interested in nutrition and health, you can explore an online dietitian degree to prepare for rewarding roles in wellness and dietetics.

Each pathway offers online flexibility, helping you build a fulfilling healthcare career even before or alongside medical school.

Best Scientists Citing Irene M. Lang

Trending Scientists

Recently Published Articles